tolbutamide has been researched along with Lipodystrophy, Intestinal in 1 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piscatelli, RL | 1 |
| Vieweg, WV | 1 |
| Havel, RJ | 1 |
1 other study available for tolbutamide and Lipodystrophy, Intestinal
| Article | Year |
|---|---|
Partial lipodystrophy. Metabolic studies in three patients.
Topics: Adipose Tissue; Adult; Body Weight; Carbohydrate Metabolism; Fatty Acids, Nonesterified; Female; Glu | 1970 |